No-Reflow Phenomenon: Maintaining Vascular Integrity

Prevention and Treatment of Microvascular Obstruction-Related Myocardial Injury and Coronary No-Reflow Following Percutaneous Coronary Intervention

(2010) Ronen Jaffe et al.   JACC-Cardiovascular Interventions

No-Reflow Phenomenon Following Percutaneous Coronary Intervention for Acute Myocardial Infarction: Incidence, Outcome, and Effect of Pharmacologic Therapy

(2010) SHEREIF H. REZKALLA et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

(2010) Gjin Ndrepepa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Coronary Microembolization

(2009) Gerd Heusch et al.   CIRCULATION

Myocardial No-Reflow in Humans

(2009) Giampaolo Niccoli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Antianginal Agent, Ranolazine, Reduces Myocardial Infarct Size but Does Not Alter Anatomic No-Reflow or Regional Myocardial Blood Flow in Ischemia/Reperfusion in the Rabbit

(2008) Sharon L. Hale et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

The Extent of Microvascular Damage During Myocardial Contrast Echocardiography Is Superior to Other Known Indexes of Post-Infarct Reperfusion in Predicting Left Ventricular Remodeling

(2008) Leonarda Galiuto et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Thrombus Aspiration during Primary Percutaneous Coronary Intervention

(2008) Tone Svilaas et al.   NEW ENGLAND JOURNAL OF MEDICINE